PMC:7600245 / 24383-24579
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T95","span":{"begin":138,"end":146},"obj":"Disease"}],"attributes":[{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Currently, favipiravir is being studied alone or in combination with tocilizumab, hydroxychloroquine, or oseltamivir for the treatment of COVID-19 in more than 23 clinical trials across the world."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T332","span":{"begin":11,"end":22},"obj":"Chemical"},{"id":"T333","span":{"begin":69,"end":80},"obj":"Chemical"},{"id":"T334","span":{"begin":82,"end":100},"obj":"Chemical"},{"id":"T335","span":{"begin":105,"end":116},"obj":"Chemical"}],"attributes":[{"id":"A332","pred":"chebi_id","subj":"T332","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A333","pred":"chebi_id","subj":"T333","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A334","pred":"chebi_id","subj":"T334","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A335","pred":"chebi_id","subj":"T335","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"}],"text":"Currently, favipiravir is being studied alone or in combination with tocilizumab, hydroxychloroquine, or oseltamivir for the treatment of COVID-19 in more than 23 clinical trials across the world."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T176","span":{"begin":0,"end":196},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently, favipiravir is being studied alone or in combination with tocilizumab, hydroxychloroquine, or oseltamivir for the treatment of COVID-19 in more than 23 clinical trials across the world."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"657","span":{"begin":11,"end":22},"obj":"Chemical"},{"id":"658","span":{"begin":69,"end":80},"obj":"Chemical"},{"id":"659","span":{"begin":82,"end":100},"obj":"Chemical"},{"id":"660","span":{"begin":105,"end":116},"obj":"Chemical"},{"id":"667","span":{"begin":138,"end":146},"obj":"Disease"}],"attributes":[{"id":"A657","pred":"tao:has_database_id","subj":"657","obj":"MESH:C462182"},{"id":"A658","pred":"tao:has_database_id","subj":"658","obj":"MESH:C502936"},{"id":"A659","pred":"tao:has_database_id","subj":"659","obj":"MESH:D006886"},{"id":"A660","pred":"tao:has_database_id","subj":"660","obj":"MESH:D053139"},{"id":"A667","pred":"tao:has_database_id","subj":"667","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Currently, favipiravir is being studied alone or in combination with tocilizumab, hydroxychloroquine, or oseltamivir for the treatment of COVID-19 in more than 23 clinical trials across the world."}